Blurbs

Wells Fargo Thinks Stevanato Group’s Stock is Going to Recover

In a report released today, Timothy Daley from Wells Fargo maintained a Buy rating on Stevanato Group (STVNResearch Report), with a price target of $19.00. The company’s shares closed last Monday at $16.55, close to its 52-week low of $14.38.

Daley has an average return of 5.9% when recommending Stevanato Group.

According to TipRanks.com, Daley is ranked #5283 out of 7909 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stevanato Group with a $23.58 average price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $29.18 and a one-year low of $14.38. Currently, Stevanato Group has an average volume of 305.7K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.

Read More on STVN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
Videos

Latest News Feed